Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Pharmacotherapy. 2021 Mar 18;41(4):405–420. doi: 10.1002/phar.2512

Table 5:

Normalized Pharmacokinetic Parameters to 2.5 mg/kg for 75 kg

Drug Cmax (ng/mL), (CV%) Tmax (hrs), (CV%) Dose-Normalized AUC(0-∞) (h*ng/mL), (CV%) # Studies Dose- and Weight-normalized RMSE RMSE Studies Included

Epidiolex
Fed 218.51 (36.37) 3.28 (34.64) 1015.45 (63.54) 9 0.41 82.12 B1-B3, H6, L1-L4, M2
Fasted 58.55 (60.52) 4.27 (23.25) 236.21 (46.05) 11 7.55 23.48 A1-A3, H1-H5, H7, H8, M1
Sativex
Fed 36.75 (59.04) 3.57 (14.01) 404206.97 (99.96) 3 0.98 263.88 D2, J3, N
Fasted 30.53 (46.03) 1.62 (32.35) 4211.42 (98.43) 10 2.33 51.21 F1-F3, G, K1-K6
Oral Capsule
Fed 77.75 (49.27) 2.44 (29.96) 240.13 (19.5) 10 0.74 222.88 C, D1, E1, E2, I1-I4, J1, J2
Fasted 46.31 (0) 1.27 (0) 6788 (0) 1 1.6 35.42 F4

Mean dose- and patient weight-normalized values correspond to the Population Pharmacokinetic (PopPK) plot generated by E.C. and transposed by A.W.